HAEMOPHILUS INFLUENZAE TYPE A

Clinical trials for HAEMOPHILUS INFLUENZAE TYPE A explained in plain language.

Never miss a new study

Get alerted when new HAEMOPHILUS INFLUENZAE TYPE A trials appear

Sign up with your email to follow new studies for HAEMOPHILUS INFLUENZAE TYPE A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Can a new vaccine stop a Lesser-Known bacterial threat?

⭐️ VACCINE ⭐️ Ongoing

This phase 2 trial is testing an experimental vaccine designed to protect against Haemophilus influenzae type a (Hia), a bacterium that can cause serious infections. Healthy adults aged 18 to 65 will be randomly assigned to receive either the vaccine or a placebo. The main goals …

Matched conditions: HAEMOPHILUS INFLUENZAE TYPE A

Phase: PHASE2 • Sponsor: InventVacc Biologicals Inc. • Aim: ⭐️ VACCINE ⭐️

Last updated Aug 05, 2026 00:00 UTC

HAEMOPHILUS INFLUENZAE TYPE A

Get alerted when new HAEMOPHILUS INFLUENZAE TYPE A trials appear

Can a new vaccine stop a Lesser-Known bacterial threat?